Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines. Zealand was founded in 1998 and is headquartered in Zealand, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA).